Linda S Elting
Biographic Data
| ID | 5535559 |
|---|---|
| NAME | Linda S Elting |
| GIVEN NAMES | Linda S |
| FAMILY NAME | Elting |
| SIGNATURE | ELTING L S |
| AFFILIATIONS | The University of Texas MD Anderson Cancer Center |
| ORCID | 0000-0002-9058-1827 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 0 |
Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in Texas
PURPOSE: To investigate end-of-life care for Medicaid, Medicare, and dually eligible beneficiaries dying of cancer in Texas. METHODS: We analyzed the Texas Cancer Registry (TCR)-Medicaid and TCR-Medicare linked databases' claims data for 69,572 patients dying of cancer in Texas from 2000 to 2008. We conducted regression models in adjusted analyses of cancer-directed and acute care and total costs of care (in 2014 dollars) in the last 30 days of l…
Factors Associated With Immunotherapy Use Among Newly Diagnosed Cancer Patients
CONTEXT: Immunotherapy represents a newer modality for cancer treatment with substantial health benefits. However, the high costs of immunotherapy may create access barriers. OBJECTIVE: To examine factors associated with the utilization of immunotherapy among newly diagnosed cancer patients. DESIGN AND SETTING: Analysis of a large national cancer registry data, the National Cancer Data Base, that represents approximately 75% of newly diagnosed ca…
No prominent works on this page.
Factors Associated With Immunotherapy Use Among Newly Diagnosed Cancer Patients
CONTEXT: Immunotherapy represents a newer modality for cancer treatment with substantial health benefits. However, the high costs of immunotherapy may create access barriers. OBJECTIVE: To examine factors associated with the utilization of immunotherapy among newly diagnosed cancer patients. DESIGN AND SETTING: Analysis of a large national cancer registry data, the National Cancer Data Base, that represents approximately 75% of newly diagnosed ca…
Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in Texas
PURPOSE: To investigate end-of-life care for Medicaid, Medicare, and dually eligible beneficiaries dying of cancer in Texas. METHODS: We analyzed the Texas Cancer Registry (TCR)-Medicaid and TCR-Medicare linked databases' claims data for 69,572 patients dying of cancer in Texas from 2000 to 2008. We conducted regression models in adjusted analyses of cancer-directed and acute care and total costs of care (in 2014 dollars) in the last 30 days of l…
Cancer (2 works) · Cancer registry (2 works) · Economic and Financial Impacts of Cancer (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Acute care (1 work) · Bevacizumab (1 work) · Cancer Immunotherapy and Biomarkers (1 work) · Cetuximab (1 work)